New Insights Into the Renin-Angiotensin System in Chronic Kidney Disease
- PMID: 32790525
- PMCID: PMC7430039
- DOI: 10.1161/CIRCRESAHA.120.317624
New Insights Into the Renin-Angiotensin System in Chronic Kidney Disease
Keywords: Editorials; aging; animals; hypertension; renin.
Conflict of interest statement
Disclosures
The authors declare no conflict of interest to disclose.
Figures

Comment on
-
Critical Role of Neprilysin in Kidney Angiotensin Metabolism.Circ Res. 2020 Aug 14;127(5):593-606. doi: 10.1161/CIRCRESAHA.119.316151. Epub 2020 May 18. Circ Res. 2020. PMID: 32418507
References
-
- Lewis EJ, Hunsicker LG, Bain RP, Rohde RD for the Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456–1465. - PubMed
-
- Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, for the RENAAL study investigation. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861–869. - PubMed
-
- Kaltenecker CC, Domeni O, Kopecky C, et al. Critical role of neprilysin in kidney angiotensin metabolism. Circ Res. 2020;xx:xxxx-xxxx. (editorial office to complete) - PubMed
-
- Emrich IE, Vodovar N, Feuer L, Untersteller K, Nougue H, Seiler-Mussler S, Fliser D, Launay JM, Heine GH. Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients. Nephrol Dial Transplant. 2019;34:100–108. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical